Amilcar (Mick) Ribeiro, MSc.

Amilcar (Mick) Ribeiro, MSc. has a range of impressive work experience in the field of clinical operations. Amilcar (Mick) is currently the Principal at Biotech Clinical Consulting LLC since November 2020. Amilcar (Mick) also holds the position of Vice President Clinical Operations at Ribon Therapeutics since January 2022. Prior to this, they served as the Vice President Clinical Operations (Interim) at Gate Neurosciences, Inc. from April 2021 to January 2022. From September 2018 to October 2020, Amilcar worked as the Vice President Clinical Operations at Gemini Therapeutics. Amilcar (Mick) also worked as the Head Of Clinical Operations at Keryx Biopharmaceuticals (acquired by Akebia) from October 2017 to September 2018. Before that, they served as the Director of Clinical Operations, Infectious Diseases at Valera LLC (subsidiary of Moderna Therapeutics) from May 2015 to October 2017. Amilcar also held various positions at Novartis Vaccines and Diagnostics, Inc. from May 2011 to May 2015, including Head, Clinical Trial Management for Region North America and Director Clinical Operations. Amilcar (Mick) started their career as a Senior Clinical Program Manager at MedImmune LLC (Subsidiary of Astra Zeneca) from April 2007 to May 2010 and as a Clinical Program Manager (Government Contractor) at SAIC-Frederick from November 2005 to April 2007. Amilcar Ribeiro's extensive experience in clinical operations and management makes him a valuable asset to any organization.

Amilcar (Mick) Ribeiro, MSc. holds a Bachelor of Science degree in Health Administration from Quinnipiac University. Additionally, they obtained a Master of Science (MSc) degree in International Business Management from Rensselaer Polytechnic Institute - The Lally School of Management.